利用核仁突出的机器学习分析预测肾癌的分级和患者生存

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-09-09 DOI:10.1002/cam4.71196
Elena Ivanova, Alexey Fayzullin, Victor Grinin, Dmitry Zhavoronkov, Dmitry Ermilov, Maxim Balyasin, Anna Timakova, Alesia Bakulina, Yusif Osmanov, Ekaterina Rudenko, Alexander Arutyunyan, Ruslan Parchiev, Nina Shved, Marina Astaeva, Aleksey Lychagin, Tatiana Demura, Peter Timashev
{"title":"利用核仁突出的机器学习分析预测肾癌的分级和患者生存","authors":"Elena Ivanova,&nbsp;Alexey Fayzullin,&nbsp;Victor Grinin,&nbsp;Dmitry Zhavoronkov,&nbsp;Dmitry Ermilov,&nbsp;Maxim Balyasin,&nbsp;Anna Timakova,&nbsp;Alesia Bakulina,&nbsp;Yusif Osmanov,&nbsp;Ekaterina Rudenko,&nbsp;Alexander Arutyunyan,&nbsp;Ruslan Parchiev,&nbsp;Nina Shved,&nbsp;Marina Astaeva,&nbsp;Aleksey Lychagin,&nbsp;Tatiana Demura,&nbsp;Peter Timashev","doi":"10.1002/cam4.71196","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Patients with clear cell renal cell carcinoma (ccRCC) often undergo organ resection, with treatment strategies based on recurrence risk. Current metastatic potential assessments rely on the WHO/ISUP grading system, which is subject to interobserver variability.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We developed an artificial intelligence (AI) model to classify cells according to contemporary grading rules and evaluated the prognostic significance of tumor cell profiles, particularly focusing on cells with prominent nucleoli.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The model accurately distinguished low (G1/G2) and high (G3/G4) grades, achieving an area under the ROC curve of 0.79. Survival analysis identified four tissue patterns defined by total cell density and the proportion of cells with prominent nucleoli. The relative abundance of such cells had greater prognostic value than their mere presence, correlating with survival times ranging from 2.2 to over 6 years. Additionally, we confirmed that dystrophic changes and focal necrosis are linked to shorter survival.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>These findings suggest that incorporating refined criteria into the WHO/ISUP system could enhance its prognostic accuracy in future revisions.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 17","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71196","citationCount":"0","resultStr":"{\"title\":\"Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence\",\"authors\":\"Elena Ivanova,&nbsp;Alexey Fayzullin,&nbsp;Victor Grinin,&nbsp;Dmitry Zhavoronkov,&nbsp;Dmitry Ermilov,&nbsp;Maxim Balyasin,&nbsp;Anna Timakova,&nbsp;Alesia Bakulina,&nbsp;Yusif Osmanov,&nbsp;Ekaterina Rudenko,&nbsp;Alexander Arutyunyan,&nbsp;Ruslan Parchiev,&nbsp;Nina Shved,&nbsp;Marina Astaeva,&nbsp;Aleksey Lychagin,&nbsp;Tatiana Demura,&nbsp;Peter Timashev\",\"doi\":\"10.1002/cam4.71196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Patients with clear cell renal cell carcinoma (ccRCC) often undergo organ resection, with treatment strategies based on recurrence risk. Current metastatic potential assessments rely on the WHO/ISUP grading system, which is subject to interobserver variability.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We developed an artificial intelligence (AI) model to classify cells according to contemporary grading rules and evaluated the prognostic significance of tumor cell profiles, particularly focusing on cells with prominent nucleoli.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The model accurately distinguished low (G1/G2) and high (G3/G4) grades, achieving an area under the ROC curve of 0.79. Survival analysis identified four tissue patterns defined by total cell density and the proportion of cells with prominent nucleoli. The relative abundance of such cells had greater prognostic value than their mere presence, correlating with survival times ranging from 2.2 to over 6 years. Additionally, we confirmed that dystrophic changes and focal necrosis are linked to shorter survival.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>These findings suggest that incorporating refined criteria into the WHO/ISUP system could enhance its prognostic accuracy in future revisions.</p>\\n </section>\\n </div>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 17\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71196\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71196\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71196","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景透明细胞肾细胞癌(ccRCC)患者经常接受器官切除术,治疗策略基于复发风险。目前的转移潜力评估依赖于WHO/ISUP分级系统,该系统受观察者之间的差异影响。方法开发人工智能(AI)模型,根据现代分级规则对细胞进行分类,并评估肿瘤细胞谱的预后意义,特别是关注核仁突出的细胞。结果该模型准确区分了低(G1/G2)和高(G3/G4)等级,ROC曲线下面积为0.79。生存分析确定了由总细胞密度和具有突出核仁的细胞比例定义的四种组织模式。这些细胞的相对丰度比它们的存在具有更大的预后价值,与生存时间相关,从2.2年到6年以上。此外,我们证实营养不良改变和局灶性坏死与较短的生存期有关。结论将改进后的标准纳入WHO/ISUP系统可提高其未来修订时的预后准确性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence

Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence

Background

Patients with clear cell renal cell carcinoma (ccRCC) often undergo organ resection, with treatment strategies based on recurrence risk. Current metastatic potential assessments rely on the WHO/ISUP grading system, which is subject to interobserver variability.

Methods

We developed an artificial intelligence (AI) model to classify cells according to contemporary grading rules and evaluated the prognostic significance of tumor cell profiles, particularly focusing on cells with prominent nucleoli.

Results

The model accurately distinguished low (G1/G2) and high (G3/G4) grades, achieving an area under the ROC curve of 0.79. Survival analysis identified four tissue patterns defined by total cell density and the proportion of cells with prominent nucleoli. The relative abundance of such cells had greater prognostic value than their mere presence, correlating with survival times ranging from 2.2 to over 6 years. Additionally, we confirmed that dystrophic changes and focal necrosis are linked to shorter survival.

Conclusion

These findings suggest that incorporating refined criteria into the WHO/ISUP system could enhance its prognostic accuracy in future revisions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信